Thalassaemia

Home
Keys to Success in Medicine
Cardiovascular System
Respiratory System
Locomotor System
Endocrine and Metabolic System
Kidneys and Urinary System
Gastrointestinal Tract
Central Nervous System
Haematological System
Integumental System
Reproductive and Genital System
Recommended Reading
Forum
Links

amazon astore

ydr

aces for paces

Clinical Skills Blogspot

 

Google
Web ydr.org.uk
acesforpaces.com medicalrevision.org

 

 

Thalassaemia

Title   

Ñ    Thalassaemia

Definition

A condition caused by:

Ñ    An imbalanced production of globin chains

Two types

Ñ    b Thalassaemia:

Impaired production of b globin chains

Ñ    a Thalassaemia:

Impaired production of a globin chains

 

 

b Thalassaemia

Title

Ñ    b Thalassaemia

Aetiology

Ñ    Inherited disorder

Pathogenesis

Ñ    Production of b chains is impaired resulting in an excess of a chains.

Ñ    This results in precipitation of the excess a chains resulting in ineffective erythropoiesis and haemolysis.

Clinical Features

Three syndromes may result:

Thalassaemia minor (Thalassaemia trait):

Ñ    Asymptomatic carrier state

Ñ    Anaemia mild or absent, red cells hypochromic and microcytic

Thalassaemia intermedia

Ñ    Moderate anaemia:

Hb 7-10g/dL

Ñ    Does not require regular transfusions

Ñ    Splenomegaly, bone deformities, leg ulcers, gallstones

Thalassaemia major (Cooley’s anaemia):

E&M

Ñ    Failure to thrive

IS

Ñ    Leg ulcers

GIT:

Ñ    Gallstones

HS

Ñ    Anaemia

Ñ    Hepatosplenomegaly:

Extramedullary erythropoiesis

Ñ    Recurrent bacterial infections

LMS

Ñ    Bone expansion:

Extramedullary erythropoiesis

Ñ    Classic thalassaemic facial features:

Frontal and parietal bossing

Enlarged maxillary bones

Investigations

Fluids

Blood

Haematology

Ñ    Hypochromic microcytic anaemia

Biochemistry

Ñ    Increased HbA2, HbF

Imaging

X-ray

Ñ    Expansion of bone marrow:

Hand x-rays

Hair on end appearance on skull x-ray

Management

Support

Biological agents

Ñ    Blood Transfusion:

To keep Hb above 10g/dL

Drugs

Ñ    Folic acid supplements:

In view of chronic haemolysis

Control

Surgery

Ñ    Splenectomy:

If transfusion requirements are high

Delayed until after the age of 6 years

Biological agents

Ñ    Bone marrow transplantation

Prevention

Ñ    Desferrioxamine and vitamin C:

To prevent iron overload, vitamin C increases urinary excretion of iron in response to desferrioxamine

 

 

a Thalassaemia

Ñ    Abnormal production of a globin chains due to gene deletions

4 genes deleted

Ñ    Severe disease with hydrops foetalis:

Pale oedematous infant with hepatosplenomegaly

Child stillborn or dies shortly after birth

3 genes deleted

Ñ    Anaemia:

Hb 7-10 g/dL

Ñ    Splenomegaly

2 genes deleted

Ñ    Microcytosis with or without mild anaemia

1 gene deleted     

Ñ    Normal

Ñ    a Thalassaemia trait

Back ] Up ] Next ]

 

 

[Up]